At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 577 enrolled
Drug / intervention
Placebo gel +2 moredrug
Likely dose
Placebo gel 1gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Benzocaine Gel Toothache Dose-Response Study
Wyeth is now a wholly owned subsidiary of Pfizer·interventional·Posted May 16, 2007·Updated Feb 28, 2013
In Brief
A Phase 4 clinical trial evaluating Placebo gel and benzocaine for Toothache. Completed, enrolled 577 participants across 8 sites.
Detailed Summary
To evaluate the efficacy and safety of benzocaine gel products for the relief of toothache and to assess the subject's compliance with proposed label directions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsToothache
CountriesUnited States
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2007
First PostedMay 2007
Primary CompletionDec 2010
TodayJul 2026
First PostedMay 16, 2007
Enrollment StartMay 1, 2007
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 19.1 years ago
Interventions
Placebo geldrug
single dose (less than 1g) of a matching placebo gel
benzocainedrug
single dose (less than 1g) of 10% benzocaine gel formulation
benzocainedrug
single dose (less than 1g) of 20% benzocaine gel formulation